Ventyx Biosciences, Inc. Contracts & Agreements
42 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (4)
- Human Resources (13)
- Real Estate (4)
- Uncategorized (8)
- Separation and Release Agreement, dated August 30, 2024, by and between the Registrant and Martin Auster (Filed With SEC on November 7, 2024)
- Offer Letter, dated December 1, 2022, by and between the Registrant and Roy Gonzales (Filed With SEC on November 7, 2024)
- Offer Letter, dated July 2, 2024, by and between the Registrant and Mark Forman (Filed With SEC on November 7, 2024)
- Consulting Agreement by and between the Registrant and Christopher Krueger, dated April 5, 2024, as amended by Amendment No. 1 to Consulting Agreement, dated September 10, 2024 (Filed With SEC on November 7, 2024)
- Securities Purchase Agreement, dated September 23, 2024, by and between the Company and the Investor (Filed With SEC on September 23, 2024)
- Amended and Restated Outside Director Compensation Policy, adopted April 3, 2024 (Filed With SEC on August 8, 2024)
- Employment letter between the Company and Mr. Moore, dated May 3, 2024 (Filed With SEC on May 16, 2024)
- Consulting Agreement by and between the Company and Christopher Krueger, dated April 5, 2024 (Filed With SEC on April 5, 2024)
- Form of Registration Rights Agreement, dated March 6, 2024, by and among the Company and the Purchasers (Filed With SEC on March 7, 2024)
- Form of Stock Purchase Agreement, dated March 6, 2024, by and among the Company and the Purchasers (Filed With SEC on March 7, 2024)
- Separation Agreement and Release, dated November 22, 2023, by and between the Registrant and William J. Sandborn (Filed With SEC on February 27, 2024)
- Consulting Agreement, dated November 20, 2023, by and between the Registrant and William J. Sandborn (Filed With SEC on February 27, 2024)
- Sublease Agreement, dated July 21, 2023, by and between the Company and Neurocrine Biosciences (Filed With SEC on July 26, 2023)
- Form of Stock Purchase Agreement, dated September 17, 2022, by and among the Company and the Purchasers (Filed With SEC on September 19, 2022)
- Form of Registration Rights Agreement, dated September 17, 2022, by and among the Company and the Purchasers (Filed With SEC on September 19, 2022)
- Lease by and between Charlotta Partners, Inc. and the Company, dated April 25, 2022 (Filed With SEC on August 15, 2022)
- Employment Letter between the Company and Dr. Sandborn, dated May 5, 2022 (Filed With SEC on May 9, 2022)
- Executive Change in Control and Severance Plan (Filed With SEC on May 9, 2022)
- Description of Common Stock (Filed With SEC on March 24, 2022)
- Executive Chairperson Services Agreement, dated as of May 14, 2021, by and between Sheila Gujrathi, M.D. and the Registrant (Filed With SEC on March 24, 2022)
- 2019 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on November 18, 2021)
- 2021 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on November 18, 2021)
- Form of Underwriting Agreement, including form of Lock-up Agreement (Filed With SEC on October 15, 2021)
- Specimen common stock certificate of the Registrant (Filed With SEC on October 15, 2021)
- 2021 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on October 15, 2021)
- 2021 Employee Stock Purchase Plan, to be in effect upon the completion of this offering (Filed With SEC on October 15, 2021)
- Confirmatory Offer Letter, dated as of October 7, 2021, by and between Raju Mohan, Ph.D. and the Registrant (Filed With SEC on October 15, 2021)
- Confirmatory Offer Letter, dated as of October 7, 2021, by and between Christopher Krueger, J.D., M.B.A. and the Registrant (Filed With SEC on October 15, 2021)
- Confirmatory Offer Letter, dated as of October 7, 2021, by and between John Nuss, Ph.D. and the Registrant (Filed With SEC on October 15, 2021)
- Confirmatory Offer Letter, dated as of October 7, 2021, by and between Martin Auster, M.D. and the Registrant (Filed With SEC on October 15, 2021)
- Lease, dated as of June 14, 2021, by and among Charlotta Partners, Inc., 9310 Towne Centre Drive Harrison-1, LLC and the Registrant (Filed With SEC on October 15, 2021)
- Master Services Agreement, dated as of January 17, 2019, by and between the Registrant and Bayside Pharma, LLC (Filed With SEC on October 15, 2021)
- Confirmatory Offer Letter, dated as of October 7, 2021, by and between the Registrant and Jrn Drappa, M.D., Ph.D (Filed With SEC on October 15, 2021)
- Standard Multi-Tenant Office Lease, dated as of September 15, 2021, by and among Charlotta Partners, Inc., 9310 Towne Centre Drive Harrison-1, LLC and the Registrant (Filed With SEC on October 15, 2021)
- Asset Purchase Agreement, dated as of February 7, 2019, by and between Vimalan Biosciences, Inc. and the Registrant (Filed With SEC on September 29, 2021)
- Share Purchase Agreement, dated as of February 26, 2021, by and among the Registrant, Zomagen Biosciences Ltd. and certain of its Securityholders (Filed With SEC on September 29, 2021)
- Share Purchase Agreement, dated as of February 26, 2021, by and among the Registrant, Oppilan Pharma Ltd. and certain of its Securityholders (Filed With SEC on September 29, 2021)
- Amended and Restated Investors Rights Agreement, dated as of September 9, 2021, by and among the Registrant and certain of its Stockholders (Filed With SEC on September 29, 2021)
- Form of Indemnification Agreement (Filed With SEC on September 29, 2021)
- 2019 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on September 29, 2021)
- Executive Chairperson Services Agreement, dated as of May 14, 2021, by and between Sheila Gujrathi, M.D. and the Registrant (Filed With SEC on September 29, 2021)
- Offer Letter, dated as of May 21, 2021, by and between William R. White, J.D., M.P.P. and the Registrant (Filed With SEC on September 29, 2021)
